Aprepitant Intravenous and Lorcaserin Extended-Release Tablets
Determining the interaction of Aprepitant Intravenous and Lorcaserin Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: aprepitant
Brand name: Cinvanti, Emend, Emend 3-Day, Emend 2-Day
Synonyms: Aprepitant
Generic Name: lorcaserin
Brand name: Belviq, Belviq XR
Synonyms: Lorcaserin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Aprepitant Intravenous-Lorcaserin Hydrochloride
- Aprepitant Intravenous-Lorcaserin Tablets
- Aprepitant Intravenous-Lorcet
- Aprepitant Intravenous-Lorcet Plus
- Aprepitant Intravenous-Lorcet Tablets
- Aprepitant Intravenous-Lorlatinib
- Lorcaserin Extended-Release Tablets-Aprepitant Oral Suspension
- Lorcaserin Extended-Release Tablets-Aprepitant/Fosaprepitant Dimeglumine
- Lorcaserin Extended-Release Tablets-Apresazide
- Lorcaserin Extended-Release Tablets-Apresoline
- Lorcaserin Extended-Release Tablets-Apresoline Injection
- Lorcaserin Extended-Release Tablets-Apri